INTEGRATED CORE STRATEGIES (US) LLC - 06 Mar 2026 SCHEDULE 13G Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
ANTX
Shares outstanding
35,509,556 shares
Disclosed Ownership
2,237,102 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
13 Mar 2026, 17:02:05 UTC
Date of event
06 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 6.3% ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX) on 06 Mar 2026."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX).
  • Disclosed ownership: 6.3%.
  • Date of event: 06 Mar 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Mar 2026, 17:02.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 6% 2,135,044 0 2,135,044 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 6.3% 2,237,102 0 2,237,102 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 6.3% 2,237,102 0 2,237,102 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 6.3% 2,237,102 0 2,237,102 /s/ Israel A. Englander Israel A. Englander

Sponsored